Anti-GM2 IgM antibodies: Clinical correlates and reactivity with a human neuroblastoma cell line

Journal of Neuroimmunology

Volumn 94, Issue 1-2, 1999, Pages 157-164

  Cavanna, B ^a   Carpo, M ^a   Pedotti, R ^a   Scarpini, E ^a   Meucci, N ^a   Allaria, S ^a   Scarlato, G ^a   Nobile Orazio, E ^a  

^a 'Giorgio Spagnol' Serv Clin N   (Italy)

Author keywords

Antibodies; Cell culture; Gangliosides; GM2; Guillain Barre syndrome; Neuroblastoma; Neuropathy

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM2; IMMUNOGLOBULIN M;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CORRELATION FUNCTION; DEMYELINATING DISEASE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MOTOR NEURON DISEASE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; G(M2) GANGLIOSIDE; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; MYELIN SHEATH; NEUROBLASTOMA; POLYRADICULONEUROPATHY; SURAL NERVE; TUMOR CELLS, CULTURED;

EID: 0033082036     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00245-8     Document Type: Article

References (39)

1. Ad Hoc subcommittee of the American Academy of Neurology AIDS Task force Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology. 41:1991;617-618.
2. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27(Suppl):1990;s21-s24.
3. Biedler J.L., Helson L., Spengler B.A. Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33:1973;2643-2652.
4. Carpo M., Nobile-Orazio E., Meucci N., Gamba M., Barbieri S., Allaria S., Scarlato G. Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Ann. Neurol. 39:1996;539-543.
5. Carpo M., Pedotti R., Lolli F., Pitrola A., Allaria S., Scarlato G., Nobile-Orazio E. Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy. J. Neurol. Sci. 155:1998;186-191.
6. Corbo M., Quattrini A., Lugaresi A., Santoro M., Latov N., Hays A.P. Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons. Ann. Neurol. 32:1992;487-493.
7. Daune G.C., Farrer R.G., Dalakas M.C., Quarles R.H. Sensory neuropathy with monoclonal immunoglobulin M to GD1b ganglioside. Ann. Neurol. 31:1992;683-685.
8. David K., Ehrhardt A., Ollert M.W., Erttmann R., Bredehorst R., Vogel C.W. Expression of a 260 kDa neuroblastoma surface antigen, the target of cytotoxic natural humoral IgM: correlation to MYCN and effects of retinoic acid. Eur. J. Cancer. 33:1997;1937-1941.
9. Ilyas A.A., Li S.C., Chou D.K.H., Li Y.T., Jungalwala F.B., Dalakas M.C., Quarles R.H. Gangliosides GM2, IVGalNAcGM1b, and IVGalNAcGD1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy. J. Biol. Chem. 263:1988;4369-4373.
10. Ilyas A.A., Willison H.J., Dalakas M.C., Whitaker J.N., Quarles R.H. Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy. J. Neurochem. 51:1988;851-858.
11. Irie S., Saito T., Nakamura K., Kanazawa N., Ogino M., Nukazawa T., Ito H., Tamai Y., Kowa H. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection. J. Neuroimmunol. 68:1996;19-26.
12. Jacobs B.C., Van Doorn P.A., Groeneveld J.H.M., Tio-Gillen A.P., Van der Meché F.G.A. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré J. Neurol. Neurosurg. Psychiatry. 62:1997;641-643.
13. Jauberteau M.O., Brindel I., Baumann I., Preud'homme J.L. Reactivity of a human monoclonal anti-GM1 and anti-GD1b IgM antibody with human neurons in cultures. J. Neuroimmunol. 48:1993;53-58.
14. Kornberg A.J., Pestronk A. Chronic motor neuropathies: diagnosis, therapy and pathogenesis. Ann. Neurol. 37(Suppl.):1995;s43-s50.
15. Krarup C., Stewart J.D., Sumner A.J. A syndrome of asymmetric limb weakness with motor conduction block. Neurology. 40:1990;118-127.
16. Kusunoki S., Shimizu T., Matsumura K., Maemura K., Manne T. Motor dominant neuropathy and IgM paraproteinemia: the IgM M-protein binds to specific gangliosides. J. Neuroimmunol. 21:1989;177-181.
17. Laemmli V.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 226:1970;680-685.
18. Li R., Ladisch S. Alteration of neuroblastoma ganglioside metabolism by retinoic acid. J. Neurochem. 59:1992;2297-2303.
19. Matsumoto A., Yoshino H., Yuki N., Hara Y., Cashman N.R., Handa S., Miyatake T. Ganglioside characterization of a cell line displaying motor neuron-like phenotype: GM2 as a possible major ganglioside in motor neurons. J. Neurol. Sci. 131:1995;111-118.
20. Nobile-Orazio E. Multifocal motor neuropathy. J. Neurol. Neurosurg. Psychiatry. 60:1996;599-603.
21. Nobile-Orazio E., Carpo M., Legname G., Meucci N., Sonnino S., Scarlato G. Anti-GM1 IgM antibodies in motor neuron disease and neuropathy. Neurology. 40:1990;1747-1750.
22. Nobile-Orazio E., Legname G., Daverio R., Carpo M., Giuliani A., Sonnino S., Scarlato G. Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b and high-molecular-weight neural-specific glycoproteins. Ann. Neurol. 28:1990;190-194.
23. O'Hanlon G.M., Paterson G.J., Wilson G., Doyle D., McHardie P., Willison H.J. Anti-GM1 ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patters in the rodent nervous system. J. Neuropathol. Exp. Neurol. 55:1996;184-195.
24. Ollert M.W., David K., Schmitt C., Hauenschild A., Bredehorst R., Erttmann R., Vogel C.W. Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells. Proc. Natl. Acad. Sci. USA. 93:1996;4498-4503.
25. Pestronk A., Chaudhry V., Feldman E.L., Griffin J.W., Cornblath D.R., Denys E.H., Glasberg M., Kuncl R.W., Olney R.K., Yee W.C. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann. Neurol. 27:1990;316-326.
26. Sadiq S.A., Thomas F.P., Kilidireas K., Protopsaltis M.S., Hays A.P., Lee K.-W., Romas S.N., Kumar N., van den Berg L., Santoro M., Lange D.J., Younger D.S., Lovelace R.E., Tojaburg W., Sherman W.H., Miller J.R., Minuk J., Fehr M.A., Roelofs R.I., Hollander D., Nichols F.T. III, Mitsumoto H., Kelley J.J. jr., Swift T.R., Munsat T.L., Latov N. The spectrum of neurological disease associated with anti-GM1 antibodies. Neurology. 40:1990;1067-1072.
27. Salazar-Grueso E.F., Routbort M.J., Martin J., Dawson G., Roos R.P. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants. Ann. Neurol. 27:1990;558-563.
28. Sasaki H., Momoi T., Yamanaka C., Yorifuji T., Kaji M., Mikawa H. Changes in the ganglioside composition of human neuroblastoma cells under different growth conditions. Int. J. Cancer. 47:1991;742-745.
29. Scarpini E., Lisak R.P., Beretta S., Velicogna M., Doronzo R., Moggio M., Jann S., Scarlato G. Quantitative assessment of Class II molecules in normal and pathological nerves. Brain. 113:1990;659-675.
30. Spagnol G., Doneda P., Cavanna B., Sgarzi M., Manfredini E., Allaria S., Scarlato G., Nobile-Orazio E. Expression of glycosylated recombinant human myelin-associated glycoprotein (MAG) on a neuroblastoma cell line and its reactivity with HNK-1 but not human anti-MAG antibodies. Neurosci. Lett. 246:1998;157-160.
31. Srinivasan J., Hays A.P., Thomas F.P., Sadiq S.A., Barth K.H.M., Liem R., Mena M.A., De Yebenes J.G., Latov N. Autoantigens in human neuroblastoma cells. J. Neuroimmunol. 26:1990;43-50.
32. Takatsu M., Hays A.P., Latov N., Abrams G.M., Nemni R., Sherman W.H., Nobile-Orazio E., Saito T., Freddo L. Immunofluorescence studies of patients with neuropathy and IgM M-proteins. Ann. Neurol. 18:1985;173-181.
33. Tettamanti G., Bonaldi F., Marchesini F., Zambotti V. A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim. Biophys. Acta. 296:1973;160-170.
34. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some application. Proc. Natl. Acad. Sci. USA. 74:1979;4350-4354.
35. Willison H.J. Antiglycolipid antibodies in peripheral neuropathy: fact or fiction. J. Neurol. Neurosurg. Psychiatry. 57:1994;1303-1307.
36. Yuki N. Anti-ganglioside antibody and neuropathy: review of our research. J. Peripher. Nerv. Syst. 3:1998;3-18.
37. Yuki N., Tagawa Y. Acute cytomegalovirus infection and anti-GM2 antibody. J. Neurol. Sci. 154:1998;14-17.
38. Yuki N., Miyatake T., Ichihashi Y., Sato S., Katagiri T. IgM anti-(GalNAc b1-4 Gal[3-2aNeuAc]b1-) antibody-mediated cytotoxicity in a patient with amyotrophic lateral sclerosis-like disorder. Muscle Nerve. 15:1992;1371-1373.
39. Yuki N., Taki T., Handa S. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylabacter jejuni enteritis. J. Neuroimmunol. 71:1996;155-161.